“Last year we listed Jardiance for a limited group of Australians with a certain type of kidney disease. But from Saturday we believe an additional 70,000 Australians with kidney disease will be eligible for this life-changing drug,” he said on Tuesday.
According to the 2021 Census, around 1 per cent of Australia’s population suffers from kidney disease, with one in 20 Australians aged 75 and over diagnosed with the disease.
‘It’s going to make a big difference’
For eligible patients without a concession card, a script now costs $31.60. Starting next year, the price will be further reduced to $25.
Health Minister Mark Butler says Jardiance, also known as Empagliflozin, is changing lives for many Australians. Source: MONKEY / Mick Tsikas
Butler said kidney disease was a silent epidemic in Australia.
#Peter #part #Australias #silent #epidemic #initiative #offers #hope


